Aevice Health vs Nautilus Biotechnology

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (37 vs 37)
Aevice Health logo

Aevice Health

EmergingBioTech

Digital Health

Aevice Health raised $30M Series B in 2025 for its AI-powered wearable respiratory monitor that continuously tracks wheezing, coughing, and breathing abnormalities in asthma and COPD patients.

AI VisibilityBeta
Overall Score
D37
Category Rank
#1 of 1
AI Consensus
65%
Trend
up
Per Platform
ChatGPT
43
Perplexity
46
Gemini
43

About

Aevice Health develops wearable respiratory monitoring technology that uses AI to analyze breath sounds captured continuously from a chest-worn device. The AeviceMD system detects wheezing, coughing, and abnormal breathing patterns in real time, enabling early warning of asthma attacks and COPD exacerbations before they require emergency care. The device transmits data to a smartphone app and clinical dashboard for remote monitoring by pulmonologists.

Full profile
Nautilus Biotechnology logo

Nautilus Biotechnology

EmergingBiotechnology

Single-Molecule Proteomics

Nautilus Biotechnology is building a single-molecule proteomics platform to map and quantify the full human proteome at a scale and sensitivity previously impossible.

AI VisibilityBeta
Overall Score
D37
Category Rank
#1 of 1
AI Consensus
64%
Trend
up
Per Platform
ChatGPT
32
Perplexity
42
Gemini
35

About

Nautilus Biotechnology is a proteomics company founded in 2016 and publicly listed on Nasdaq, developing a revolutionary platform for analyzing proteins at single-molecule resolution. While genomics has transformed medicine through DNA and RNA sequencing, the proteome is the actual functional layer of biology where drug targets, disease biomarkers, and therapeutic mechanisms operate. Nautilus is building a platform that can identify and quantify thousands of proteins simultaneously from tiny biological samples using a fluorescence-based single-molecule detection approach without requiring mass spectrometry. The platform promises to enable proteomics studies at a scale and depth comparable to what next-generation sequencing delivered to genomics, unlocking new insights into disease biology and drug development. Nautilus is in the instrument development phase and targets pharmaceutical research, clinical diagnostics, and academic biology. The company has raised over $250M and is building manufacturing capabilities for a planned commercial instrument launch that could define a new era in proteomics research.

Full profile

AI Visibility Head-to-Head

37
Overall Score
37
#1
Category Rank
#1
65
AI Consensus
64
up
Trend
up
43
ChatGPT
32
46
Perplexity
42
43
Gemini
35
32
Claude
31
36
Grok
44

Key Details

Category
Digital Health
Single-Molecule Proteomics
Tier
Emerging
Emerging
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Aevice Health
Digital Health
Only Nautilus Biotechnology
Single-Molecule Proteomics

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.